Tamyra Toole joined Rubius in June 2018. She brings to Rubius more than 20 years of regulatory affairs and quality assurance experience in the biotechnology and pharmaceutical industry.
Prior to joining Rubius, she served as an independent regulatory affairs consultant to biotechnology companies. Prior to her role as a consultant, Tamyra was the Vice President of Regulatory Affairs and Quality Assurance at Infinity Pharmaceuticals, where she built the regulatory and quality teams and was responsible for the global regulatory strategy and the company’s compliance with quality regulations and standards. Previously, Tamyra held positions in regulatory affairs and quality assurance at NitroMed, Wyeth Pharmaceuticals, Millennium Pharmaceuticals and Organogenesis, Inc. She has experience in the development of drugs, biologics and early cell therapies across multiple therapeutic areas. Prior to working in drug development, Tamyra held various positions in the Department of Nursing at Brigham and Women’s Hospital.
Tamyra holds a B.S. in nursing from Villanova University and a J.D. from the Catholic University of America.